Category Archives: Concentrics News

Concentrics Research attending CHPA’s Regulatory & Scientific Affairs Committee

Posted September 19th, 2013. Filed under Concentrics News

Julie Aker, President & CEO and Sara Travis, Director of Operations will be attending CHPA’s Regulatory & Scientific Affairs Committee in Washington, D.C. on October 23rd.

Julie Aker, President & CEO, to present at annual DIA Conference in Boston

Posted June 20th, 2013. Filed under Concentrics News

Julie Aker, President & CEO for Concentrics Research, to present the results of novel research planned and conducted in partnership with GlaxoSmithKline to create a better form of Patient Medication Information (PMI).  Other panelists will be from Novartis, the National Health Council, FDA and Eisai.  Currently three documents serve to communicate patient product information for prescription drugs:  the patient package insert, the medication guide, and consumer medication information.  None are deemed to be optimal.  This session will discuss how the FDA will attempt to remedy this through the one-document solution.  Read More.

Concentrics Research Adds Senior Staff

Posted May 22nd, 2013. Filed under Concentrics News

Indianapolis, IN (PRWEB) May 22, 2013

Concentrics Research LLC, a privately held business specializing in consumer healthcare research and late-stage clinical research, is pleased to announce that Todd Lehman has joined the company as Chief Operating Officer and Doug Gorr has joined the company as Director of Technology Solutions.

Lehman joins the senior leadership team with extensive experience and a rich background in creative approaches to late stage research, including most recently as director of global late stage research operations for PPD, Inc.  Lehman holds a masters in biomedical engineering and a bachelors in chemical engineering from the University of South Florida.  Gorr joins Concentrics with a strong background in IT strategy and emerging technologies and he was previously with Nightingale Home Healthcare.  Gorr holds a bachelor’s in computer information systems, process management, and operations from the Kelly School of Business at Indiana University.  “We are extremely excited to add talent to our senior leadership team and we intend to leverage the experience of our new executives and existing leaders to create innovations to further improve health,” said Julie Aker, president and CEO of Concentrics.

To learn more about Concentrics Research, visit http://www.concentricsresearch.com.

About Concentrics Concentrics Research LLC is a niche late-stage contract research organization that serves the pharmaceutical and device industries. The Company is devoted to client-centered strategies for Rx-to-OTC Switch programs, consumer healthcare research and Phase II-IV clinical trials.  Concentrics is a leader in late stage research and research for over-the-counter products.  The company works closely with the U.S. Food and Drug Administration, National Institutes of Health, and Centers for Disease Control and Prevention on key industry initiatives and they are involved with pharmaceutical companies in key strategy development and study execution.  Concentrics has offices in Indianapolis, Indiana and Parsippany, New Jersey.

Contact:

Julie Aker | President and CEO
Concentrics Research
317.706.3201

Julie Aker, President & CEO, presentation at the Brookings Institution related to the Nonprescription Safe Use Regulatory Expansion (NSURE) initiative

Posted May 9th, 2013. Filed under Concentrics News, Industry Headlines

Julie Aker, President & CEO for Concentrics Research, was invited to be part of an expert panel, to discuss how consumers might benefit from using technology-assisted decision making.  Julie reviewed the types of decisions that consumers make when viewing a new over-the-counter (OTC) product and how technology might assist in these key decisions.  She also gave examples of how specific types of technology could be used at different stages of decision-making and to facilitate improve long-term compliance. Read more.

Concentrics Research sponsored part of the annual Consumer Healthcare Products Association (CHPA) meeting and exhibited capabilities via a virtual video tour

Posted May 2nd, 2013. Filed under Concentrics News

The annual Consumer Healthcare Products Association (CHPA) meeting was held in Washington, D.C. on May 2-3, 2013.  Concentrics Research was an affiliate sponsor of the program and also exhibited at the conference.  This year, Concentrics provided a novel video tour that allowed all participants to see the staff, facilities and capabilities of Concentrics in a new way.  Click here to view the tour…

 

Concentrics Research is Recertified as a Women’s Business Enterprise in 2013!

Posted April 2nd, 2013. Filed under Concentrics News

Concentrics Research has been Recertified as a Women’s Business Enterprise in 2013!

More…

 

 

Concentrics Research Receives National Certification

Posted March 30th, 2010. Filed under Concentrics News
 

Designation as Women’s Business Enterprise coincides with 25th Anniversary; Provides platform for accelerated growth

INDIANAPOLIS, IN – March 25, 2010 – Concentrics Research LLC, a privately held business specializing in consumer healthcare research and late-stage clinical research, has received national certification as a Women’s Business Enterprise by the Women’s Business Enterprise Council – Great Lakes [a regional certifying partner of the Women’s Business Enterprise National Council (WBENC)]. Celebrating their 25th Anniversary, Concentrics Research highlights this designation as they further strengthen partnerships with a growing network of pharmaceutical and medical device companies throughout the United States.

 

“We are very excited about this national certification and it coincides with our plans for further expansion. Concentrics remains committed to furthering the health and quality of life for consumers by partnering with our sponsors on innovative research programs,” Concentrics Research President and CEO Julie L. Aker said. “We have been involved in 76% of the successful Rx-to-OTC Switch programs and have more than doubled our client base over the last 5 years. This certification will open the door to new opportunities and we look forward to expanding our reach and the impact we can make in the industry.”

 

WBENC’s national standard of certification confirms a business is at least 51% owned, operated and controlled by a woman or women. By including women-owned businesses among their vendors, corporations and government agencies demonstrate their commitment to fostering diversity and the continued development of their supplier/vendor diversity programs.

 

Concentrics works with Fortune 100 pharmaceutical and device companies to provide a full range of contract research organization (CRO) services that range from program strategy and FDA interactions to protocol development and full study execution for Rx-to-OTC Switch programs, clinical studies (Phase II-IV), behavioral studies related to Rx-to-OTC Switch (label comprehension, self-selection and actual use) and healthcare marketing research studies to support claims and line extensions. Concentrics also is widely known for their expertise with REMS (Risk Evaluation and Mitigation Strategies), a growing area resulting from recent FDA expectations.

 

To learn more about Concentrics Research, visit www.concentricsresearch.com

 

About Concentrics

Concentrics Research is a late-stage contract research organization that serves the pharmaceutical and device industries. The Company is devoted to client-centered strategies for Rx-to-OTC Switch programs, consumer healthcare research and Phase II-IV clinical trials.

 

 

# # #

 

 

CONTACT:

Julie L. Aker

Phone: 317/706-3200

Fax: 317/705-2180

E-mail: julie.aker@concentricsresearch.com